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ABSTRACT  
Diabetes is a complex chronic disease which requires patients to integrate numerous actions 
into their daily lives for successful management. Peer leader supported diabetes self-
management support (DSMS) is a promising efficient method for delivery of diabetes education 
in high risk communities. 
The objective of this study was to evaluate the effectiveness of a peer leader supported 
DSMS program on the Patient Assessment of Care for Chronic Conditions (PACIC).   This paper 
specifically focused on the impact of peer leaders on patient-rated experience of self-
management support as measured by the PACIC.  The study was a prospective, multisite, 
cluster randomized controlled trial. The intervention group received diabetes self-management 
education (DSME) plus peer leader supported DSMS, while in the control group, patients 
participated in DSME and DSMS conducted by diabetes educators. Two-hundred-twenty-one 
patients with diabetes were recruited from seven primary care practices at baseline, 119 in the 
intervention group and 102 in the control group. 
The overall PACIC score was not significantly associated with the peer leaders support, 
however the model revealed a significant positive interaction between the groups and the 
change in the slope of the PACIC score throughout the study (p=0.004).  This indicated that 
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there was a steeper increase in total PACIC scores over time in the intervention group than in 
the control group. PACIC scores increased with baseline PACIC scores, but the increasing rate 
declined as baseline scores increased. In this study, there were no associations between the 
PACIC score and age or education level. However, there was a relationship between overall 
Diabetes Empowerment Scale score and total PACIC score. Associations were also seen in the 
subscales of patient activation, delivery system design, collaborative problem solving and follow 
up. 
This study provided a patient-centered approach to assess the quality of service in a 
peer support DSMS program. Additionally, given limited health resources, this study has public 
health significance in confirming that peer leader supported DSMS can make greater use of 
community resources and gain similar effectiveness at lower cost. 
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1.0 INTRODUCTION 
1.1 DIABETES  
Diabetes mellitus is one of the most common chronic diseases in the United States. According 
to national statistics, diabetes affects 25.8 million people of all ages, 8.3 percent of the U.S. 
population[1]. About 1.9 million people aged 20 years or older were newly diagnosed with 
diabetes in 2010[1]. A CDC study projected that one of three U.S. adults could have diabetes by 
2050 if current trends continue[2]. Type 2 diabetes is the most common form of diabetes, 
accounting for about 95% of diagnosed diabetes in adults[1] .  
 Diabetes is a metabolic disease in which the body fails to produce any or enough insulin, 
resulting in elevated levels of glucose in the blood[1]. Diabetes is caused by a variety of factors, 
such as obesity, physical inactivity, insulin resistance, genetic susceptibility, and environmental 
factors[3].  Obesity and physical inactivity are strongly associated with the development of type 
2 diabetes, and cause insulin resistance, a condition in which the body does not use insulin 
effectively[3]. Diabetes can lead to serious complications such as blindness, kidney damage, and 
neuropathy. Having diabetes can also increase the risk of heart disease, stroke and peripheral 
vascular disease[3].   
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1.2 DIABETES THERAPY 
Diabetes is a complex disease requiring an integrated therapeutic approach. It is essential in 
this integrated care approach that individuals with diabetes assume an active role in their 
care[4]. The primary goal of diabetes care is to prevent acute complications and reduce the risk 
of long-term complications in people of diabetes. There is abundant evidence to show that risk 
of microvascular and macrovascular complications is related to glycemia, as measured by A1C, 
which is a major focus of therapy[5-7]. Hemoglobin A1C is a minor component of hemoglobin to 
which glucose is bound. The level of A1C depends on the blood glucose concentration. That is, 
the higher the glucose concentration in blood, the higher the level of A1C.  Results of some 
prospective randomized trials have demonstrated that tight control of blood glucose can 
prevent or delay diabetic complications [8, 9]. According to 2014 Standards of Medical care in 
Diabetes, a reasonable glycemic goal for nonpregnant adults is less than 7%. But the A1C goal 
can be varied from 6.5% to 8% depending on individual situations[4].  
1.2.1 Pharmacological Therapy 
Advances in pharmacologic therapy have increased the treatment options available to people 
with diabetes.  However, information on whether specific agents are able to control glycemia 
without adversely affecting quality of life is incomplete; answering to these questions requires 
long-term, large scale clinical trials which are not available for most drugs.  The Standards of 
Medical Care in Diabetes 2014 from the American Diabetes Association reaffirm the four-step 
strategy of pharmacological therapy[4]. A patient-centered approach is recommended, 
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accounting for patient preferences, cost, potential side effects of each class, impacts on body 
weight, and risk for hypoglycemia[4]. 
It is generally agreed that metformin, barring contraindication or intolerance, is the 
preferred and most cost-effective first agent. Metformin, a biguanide, has a long-standing 
evidence base for efficacy and safety, which predominately involves reducing hepatic glucose 
production [10]. It is initiated at or soon after diagnosis, particularly when lifestyle efforts alone 
have not achieved or are unlikely to achieve glycemia goals.  
When metformin fails to achieve or maintain glycemia goals over 3 months, another 
agent should be added, which could be sulfonylurea, thiazolidinedione, DPP-4 inhibitor, GLP-
1receptor agonist or basal insulin [11]. If the glycemic targets are not achieved after 3 months, 
adding insulin to a two-drug combination could have a more robust response, compared to 
adding a third noninsulin agent. In using triple combinations, the essential consideration is to 
use agents with complementary mechanisms of action. [12] 
Diabetes is a progressive disease. Many patients with diabetes eventually require and 
benefit from insulin therapy. Basal insulin alone is usually the optimal initial regimen, beginning 
at 0.1-0.2 units/kg body weight.[4] If combination therapy that included basal insulin has not 
worked after 3 to 6 months, it is necessary to proceed to a more complex insulin strategy, 
depending on patients’ condition, either twice-daily premixed insulin or basal plus mealtime 
insulin. Individualization of therapy is key, incorporating the degree of hyperglycemia and the 
overall capacities of the patient[4].       
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1.2.2 Lifestyle Change 
Healthy eating   A position statement from ADA illustrated the benefit of healthy eating for 
those with diabetes, including improvement in blood glucose control, improvement of lipid 
profiles, maintenance of blood pressure in the reference range, and weight loss or weight 
maintenance[13].  
Individuals with diabetes are recommended to receive Medical Nutrition Therapy 
(MNT), preferably provided by a registered dietitian who is familiar with the components of 
diabetes MNT[4].  However, there is no consistent evidence suggesting a clear nutrition 
intervention[14]. There is no one set of nutrition recommendations or interventions that apply 
to all persons with diabetes. Instead of specific healthy eating or dietary interventions, an 
individualized approach with nutrition recommendations is developed to meet treatment goals 
and desired outcomes. Using this approach, nutrition intervention is dynamic and determined 
by nutrition assessments and expert opinion, combined with individual patient needs[15]. 
Exercise    Physical activity has long been one of the cornerstones in diabetes management. 
Persons with type 2 diabetes are recommended to undertake at least 150 min/week of 
moderate to vigorous aerobic exercise, combined with resistance training at least 2–3 
days/week[4]. Studies provide considerable evidence for the benefits of aerobic training and 
resistance training in improving insulin action and management of blood glucose, lipids, and 
blood pressure[16-19].           
Varying type of regular exercise has continued benefits, although their outcomes are 
often apparently in conflict. Results of studies are often contradictory and can be explained by 
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the variability in measurements and exercise interventions including their duration (of both 
individual exercise sessions and length of participation), intensity, and mode of physical 
activity[20].  The current knowledge base still strongly supports the assertion that becoming 
and remaining physically active is critical to living long and well with diabetes[4].   
1.2.3 Psychosocial Support 
It is critical to include assessment and screening for psychological and social support as an 
ongoing part of the management of diabetes. Multiple studies have found psychological and 
social problems are associated with hyperglycemia [21, 22] and impair patients’ ability to carry 
out diabetes self-management which may compromise their health status [23]. Psychosocial 
support refers to a continuum of care and supports which influence both the individual and the 
social environment in which people live. It emphasizes the need to view these issues within the 
interpersonal contexts of wider family and community networks in which they are located.[24] 
A systematic review showed a modest A1C lowering in psychosocial interventions, but a limited 
association between effects on A1C and mental health [25]. 
Psychological problems include depression, diabetes-related distress, anxiety, eating 
disorders, and cognitive impairment[4]. One review clarified the difference between depression 
and diabetes-related distress. Diabetes distress refers to a broad range of emotional responses 
to specific acute or chronic stressors and is a progressive process[23], which can be measured 
by Problem Areas in Diabetes (PAID) or the Diabetes Distress Scale (DDS). One study reported 
insulin-treatment led to higher diabetes-related emotional distress compared with those 
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treated with oral medication or diet [26]. Greater distress was largely explained by greater 
disease severity and self-care burden [26]. 
Diabetes distress is related to specific stressors and Fisher et al. suggested that 
identifying the content of the distress during the intervention were necessary and would make 
the intervention more efficient [23]. Another study showed the benefit from ongoing DSME and 
DSMS which consider distress as an expected part of diabetes [27].  
Reducing depressive symptoms might also improve patient self-management with 
consequent benefits for diabetes outcomes [28]; in return, improved diabetes control might 
reduce distress associated with complications and poor physical health, and enable an 
individual to better handle other stressful life events. However, clarifying different types of 
psychological issues and achieving simultaneous improvements with low cost and effective 
interventions presents a challenge.  
1.3 CHRONIC CARE MODEL 
Under a system designed for acute symptoms, patients with chronic illness often receive care 
which features a passive patient interacting with an unprepared practice team, resulting in 
ineffective encounters and frustrating outcomes[29]. The Chronic Care Model (CCM) can lead 
to a higher-quality of chronic illness management [30].  Chronic care usually takes place within 
three overlapping galaxies: the entire community, with its myriad of resources and numerous 
public and private policies; the health care system; and the provider organization, like small 
clinics, or a loose network of physician practices[30]. Within this trigalactic universe, the 
7 
workings of each component may help or hinder optimal chronic care. The CCM identified six 
interrelated elements: self-management support, clinical information systems, delivery system 
redesign, decision support, health care organization, and community resources. Assessment 
tools were designed to assess the primary tenets of the CCM, such as the Assessment of 
Chronic Illness Care (ACIC) and the Patient Assessment of Chronic Illness Care (PACIC). The ACIC 
is intended for use by medical teams to identify areas for improvement and to evaluate the 
level and nature of improvements made in response to quality improvement interventions[31]. 
The PACIC provides an approach to evaluate the quality of chronic illness care delivery from the 
patient perspective and reflects patient satisfaction [32]. 
Care modeled after the CCM includes providing self-management support to patients 
through goal-setting, follow-up, and links to community resources, as well as providing support 
to care providers through delivery system redesign, decision support, and clinical information 
systems [33]. Patient-centered care is defined as: “providing care that is respectful of and 
responsive to individual patient preferences, needs, and values and ensuring that patient 
values guide all clinical decisions”.[34] Both patient-centered care and the CCM call for efforts 
to assess and understand patient’s information in multiple aspects to individualize treatment, 
and emphasize the importance of patient participation in the process of treatment, and a more 
active role to play in defining and reforming healthcare to achieve optimal care. Therefore, 
CCM is viewed as fundamentally patient-centered because of concordance between the 
dimensions of patient-centered care and the features of self-management support[35]. 
For patients with diabetes, self-management support is a critical element of care in 
CCM. Patients have to live with diabetes for many years and deal with the day to day 
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management of their illness including diet, exercise, glucose monitoring, and medication use. 
Self-management support involves helping patients and their families acquire the skills and 
confidence to manage their chronic illness, and routinely assessing problems and 
accomplishments [30]. According to CCM, self-management support is supposed to build on the 
other elements of the CCM to produce higher-quality care in which informed, activated patients 
interact with prepared, proactive practice teams. Diabetes self-management education (DSME) 
and peer leader supported diabetes self-management support (DSMS) primarily fit into self-
management support and the community resource elements in CCM.  Therefore, the Patient 
Assessment of Chronic Illness Care (PACIC) was used as an instrument to measure patients’ 
perceptions of the quality of the self-management support received and to assess the extent to 
which care received aligns with CCM[36]. 
1.4 DIABETES SELF-MANAGEMENT EDUCATION AND SUPPORT 
Diabetes is a complex disease requiring patients to integrate numerous actions (e.g., taking 
medication, monitoring glucose, eating healthily, being active) into their daily lives for 
successful management. However, patients are not always adept at self-management skills, 
including basic knowledge acquisition, skill in applying practical information, setting realistic 
goals, problem solving, coping and self-efficacy. In addition, many people with diabetes have or 
are at risk for developing comorbidities, including both diabetes-related complications or other 
medical conditions that may make self-care even more difficult[33]. As recommended in the 
Standards of Medical Care in Diabetes 2014, diabetes self-management education (DSME) and 
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diabetes self-management support (DSMS) are essential elements of diabetes management[4]. 
The overall objectives of DSME and DSMS are to support informed decision making, self-care 
behaviors, problem solving and active collaboration with the health care team to improve 
clinical outcomes, health status, and quality of life in a cost-effective manner[37].  
1.4.1 Diabetes self-management education (DSME) 
DSME is the ongoing and evidence-based process of facilitating the knowledge, skill and ability 
necessary for prediabetes and diabetes self-care, incorporating the needs, goals and life 
experiences of patients[38].  The American Association of Diabetes Educators (AADE) defined 
seven diabetes self-care behaviors as key behaviors to DSME. They are healthy eating, being 
active, monitoring, taking medication, problem solving, healthy coping, and reducing risks. 
Multiple studies have shown that DSME is associated with improved diabetes knowledge and 
improved self-care behavior [38, 39], positive effects in clinical outcomes[40] and quality of 
life[41]. 
DSME is mainly provided by registered nurses, registered dietitians, pharmacists or 
other professionals with certification in diabetes care and education. There is no overt 
discrepancy in the effectiveness and quality of services delivered by different professionals [39, 
42]. However, a body of studies endorse a multidisciplinary team approach to diabetes 
education [43, 44]. People with diabetes should receive medical care from a collaborative team, 
which can include, but is not limited to physicians, nurses, dietitians, pharmacists and mental 
health professionals. 
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DSME can be offered via an evidence-based and flexible set of courses, the content of 
which can include practical problem-solving approaches, behavior change, psychosocial issues 
and strategies to sustain self-management efforts[38]. The most successful diabetes-specific 
self-management group classes that have been rigorously evaluated to date are based on 
empowerment theory[45]. Empowerment is the process of discovery and development of one’s 
inherent capacity to be responsible for one’s own life [46]. People are empowered when they 
have sufficient knowledge to make rational decisions, sufficient control and resources to 
implement their decisions, and sufficient experience to evaluate the effectiveness of their 
decisions.  Empowerment-based patient education is designed to improve quality of life by 
enabling them to take charge of their health through recognition and promotion of individual 
strengths, informed choices and personal goals, instead of enhancing their compliance with the 
treatment recommendations[47].    
1.4.2 Diabetes self-management support (DSMS) 
Diabetes self-management support (DSMS) refers to activities that assist the person with 
prediabetes or diabetes in implementing and sustaining the behaviors needed to manage his or 
her condition on an ongoing basis beyond or outside of formal self-management training[38]. A 
variety of strategies are available for providing DSMS both within and outside the DSME 
organization, such as involving trained peers, ongoing education, support groups and 
information technology[48, 49]. Better clinical outcomes and self-care behaviors were reported 
for DSME intervention that included follow-up support (DSMS) [50, 51]. 
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While DSME is necessary and effective in diabetes care management, current short-
term DSME interventions have not been shown to persist over the long term [39, 52].  Ongoing 
DSMS is needed to help people with diabetes maintain effective self-management throughout a 
lifetime of diabetes as they face new challenges and treatment advances become available[38]. 
Additionally, because self-management takes place in a patient’s daily life and not in clinical or 
educational settings, it is critical for patients to seek community-based resources that may 
support their ongoing diabetes self-management with assistance from DSMS providers. Finally, 
many DSME interventions follow organized lesson plans to deliver information in a prescribed 
order using a classroom approach. DSMS can reinforce and enhance self-management gains 
achieved from initial DSME programs under real-world environment and life circumstances.  
1.4.3 Peer supported DSMS 
With the increasing prevalence of diabetes and resource constraints worldwide, it is imperative 
to develop and evaluate efficient methods for delivery of DSMS in high risk communities. Most 
DSME programs, to some degree, have failed to provide enough self-management support due 
to lack of personnel with protected time or budget limitations. Although the importance of 
DSME is known and attempts to sustain follow-up are being made, the number of DSME 
programs and educators cannot meet the demands of the increasing rates of diabetes, 
especially in low-income communities [53, 54]. To bridge the gap between supply and demand, 
having peer support involved in DSME is a potential solution. A recent report from the World 
Health Organization (WHO) indicated that peer support offers a promising solution and 
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presented recommendations for developing and evaluating peer support programs (WHO, 
2007). There is a growing body of literature considering peer supported DSME and DSMS as a 
promising approach [45, 55]. 
Peer support is “the provision of emotional, appraisal and informational  assistance by a 
created social network member who possesses experiential knowledge of a specific behavior or 
stressor and similar characteristics as the target population, to address a health-related issue of 
a potentially or actually stressed focal person.”[56] A peer is someone who has been successful 
in managing his or her conditions and is able to provide relevant and meaningful information to 
others with the same condition [57]. Through training, peers are able to voluntarily help 
individuals with diabetes overcome psychosocial barriers through empathy, support, enhanced 
knowledge, and obtain health care professional assistance.  
There is no one standard set of peer support that applies to all persons with diabetes 
under various cultural and demographic circumstances. However, actual provision of peer 
support comprises four key functions, developed by the Peers for Progress initiative [58, 59].  
This offers a standardized structure in which peer support programs may be built and 
evaluated.   In the scope of DSME, the four key functions of a peer leader consist of assisting in 
self-management, providing social and emotional support, linking patients to clinical care, and 
providing ongoing support [58, 60].  
Indeed, the evidence is sparse for the effectiveness of peer leaders improving clinical 
outcomes; however, the literature is beginning to consistently demonstrate that peer leaders 
are effective at facilitating behavior change such as physical activity and helping individuals to 
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improve their self-efficacy[55]. However, more studies are required to support firm 
recommendations, particularly for consistent benefit of glycemic control [55, 61]. 
1.5 PURPOSE OF STUDY 
Although a growing number of studies investigated the beneficial role of peers in DSME and 
DSMS[45, 55, 61], many questions remain unanswered, including influences on patient 
centeredness, impact on clinical and psychological outcomes, and the ability of practitioners 
and health care systems to implement, adopt, and maintain patient-centered interventions 
over time. 
Therefore, the objective of this work is to evaluate the impact of a peer leader 
supported DSMS program on an array of patient outcomes. This paper specifically focused on 
the impact of peer supported DSMS on patient outcomes as measured by the PACIC.  
Hypothesis 1: Participants in peer supported DSMS programs will have higher total PACIC 
scores, compared with those who do not receive peer supported DSMS. 
Hypothesis 2: Compared with those who do not receive peer supported DSMS, participants in 
peer supported DSMS programs will have higher scores on the five subscales of the PACIC- 
patient activation, delivery system design, goal setting, problem solving and follow up, 
respectively. 
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2.0 METHODS 
2.1 STUDY DESIGN 
2.1.1 Study Setting 
This analysis was conducted using data from Project SEED: Support, Education, and Evaluation 
in Diabetes. The project objective was to evaluate the effectiveness of peer leader supported 
vs. non-peer leader supported DSMS programs in rural primary care sites. 
The study was a prospective, multisite, cluster randomized controlled trial with the 
primary care office as the unit of randomization.  
Participants were recruited from patients with diabetes at six rural primary care 
practices in Southwestern, Pennsylvania from April 1, 2011 to March 21, 2012. The six recruited 
primary care practices were randomized to the intervention group which involved DSME plus 
peer leader supported DSMS or control group which contained DSME and DSMS conducted by 
diabetes educators. 
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Due to failure in achieving recruitment goal, the Uniontown office of Centerville Clinics, 
as the extension of Carmichaels clinic, was added in the second phase of recruitment from June 
29, 2012 to September 30, 2012.  
Inclusion criteria were individuals with type 1 or type 2 diabetes over age 18 (ICD9 code 
250.xx) receiving care at one of seven primary care practices, comprising Carmichaels clinic, 
Uniontown Clinic, Joseph F. Yablonski Memorial Clinic, Washington Family Doctors, Partners in 
Health (Murrysville), Partners in Health (Level Green), Partners in Health (Delmont). Individuals 
who did not have diabetes, those with gestational diabetes or non-ambulatory patients were 
excluded in this study. Participants were recruited via mailings, referrals of physicians and 
diabetes educators in practices, and advertising in local media publications. 
2.1.2 Peer Leaders and Training  
Peer leaders in this project had to meet the following criteria: having diabetes, being a patient 
in one of the intervention practices, having attended diabetes self-management education and 
possessing inherent qualities, such as empathy, which would lend them to being a successful 
peer leader. 
Eligible peer leader candidates were selected from the intervention practices (Carmichaels, 
Delmont, Uniontown and Murrysville) based on the recommendations from diabetes educators 
or physicians in the practices. Glycemic control was not one of the eligibility criteria for a peer 
leader as there are controversial results showing whether good glycemic control was associated 
with being a successful peer leader  [62-66]. 
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Peer leader candidates were identified one to two months prior to the start of the 
intervention to allow time for training. Candidates who expressed interest in serving as a peer 
leader were invited to the peer leader training held by the diabetes educator, which included 2-
3, 2-hour training sessions in addition with follow-up sessions for each peer leader.  The 
University of Michigan Peer leader Training Curriculum, developed by Dr. Tricia Tang and Ms. 
Martha Funnell, was used to train the study’s peer leaders how to facilitate self-management 
support groups.  All peer leaders signed an agreement before beginning their work as peer 
leader, outlining their responsibilities in this role.  
2.1.3 Intervention 
This study was carried out in three phases (Figure 1). The major part of phase 1 was DSME and 
the interventions in phase 2 and phase 3 were DSMS. Both of DSME and DSMS was based on 
the empowerment approach[47], which focused on reflecting on participants’ self-management 
experiences, discussing their emotional experience of living with diabetes, engaging in 
systematic patient-centered goal setting and problem solving.  The University of Pittsburgh 
approved the study and all patients provided informed consent prior to any procedures. 
Phase 1 (Baseline Assessments+ DSME + Post-DSME Assessments):  
Participants in both groups completed demographic data and baseline assessments before the 
intervention. In the intervention group, participants were offered four weekly DSME classes and 
peer leaders also attended. Activities in the control group and the contents of DSME classes 
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were identical to those in the intervention practices with the exception that there was no peer 
leader attending. In DSME sessions, participants received their clinical data results along with 
information about self-care behaviors [53]. All of the same data that were collected at baseline 
were also collected following DSME, starting on May 1, 2011. 
The DSME curriculum was based on the ADA Standards for DSME[37]. The core content 
of the curriculum stemmed from the American Association of Diabetes Educators 7 Self Care 
Behaviors[38] and the American Diabetes Association Medical Standards of Care[4].  
Phase 2 (Support Group+ 6 months Assessments):   
Following DSME, participants were invited to attend a series of six monthly support group 
meetings from June 1, 2011 to April 2013, which addressed discussions for overcoming 
challenges in management, goal setting, and problem solving. The same content was provided 
and discussed in support groups for both intervention and control groups; however, the peer 
leader facilitated the intervention practice support groups, whereas the diabetes educator 
facilitated the sessions for the control groups. Participants in both groups completed post 
support group assessments at 6 months after intervention. 
Phase 3 (Monthly phone calls+12 months assessments):   
Following the series of six monthly support groups, participants received monthly support via 
phone calls. The phone call log (Appendix A) was used for both intervention and control 
practices to capture data related to medication changes, previous short-term goals, future 
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short-term goals, and progress and confidence in achieving the goals. The calls were made by 
peer leaders in the intervention practices, and by diabetes educators in control practices.  
Participants in the intervention groups received a more thorough talk about goal setting and 
long term self-management from peer leaders, compared with routine follow up calls from 
diabetes educators in the control group. Participants in both groups completed assessments at 
12 months post intervention.   
2.2 MEASUREMENTS 
2.2.1 Clinical Measurements 
Clinical measurements in the project included A1C (%), blood pressure (mmHg), weight (lbs), 
height (inches), BMI (kg/m2), LDLc (mg/dL), triglyceride levels (mg/dL) and total cholesterol 
(mg/dL) (Table 1). In order to capture fasting laboratory values for A1C and lipids, all 
participants were provided with a lab requisition form to take to their local lab to have their 
blood drawn. Results were then faxed to the study team and the participants and their 
physicians were provided with the results. Appendix B is a copy of the lab requisition form and 
an example of the participant results. Blood pressure was assessed according to the 
Hypertension Detection and Follow-Up (HDFP) protocol. Three consecutive BP readings (right 
arm, sitting) using a standard mercury manometer were taken.   
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2.2.2 Sociodemographic And Survey Measurements 
Sociodemographic data Sociodemographic data were collected at baseline, which consisted of 
age, gender, ethnicity, type of diabetes, yearly income and education level. 
Diabetes Distress Scale (DDS) The diabetes distress scale (DDS) measures diabetes-related 
emotional distress and consists of four unique subscales, which when summed together, 
produce a total diabetes distress score, ranging from 1 to 6 (higher score is worse). The four 
scales that make up the DDS include Emotional burden, Interpersonal Related Distress, 
Physician related distress, and Regimen related distress. The higher score indicated the severer 
diabetes-related distress. The DDS has a consistent, generalizable factor structure and good 
internal reliability (Cronbach's coefficient alpha > 0.87) [67]. (Appendix C) 
SF-12 The 12-Item Short Form Health Survey (SF-12) was developed for the Medical Outcomes 
Study (MOS), a multi-year study of patients with chronic conditions. The SF-12 was used to 
measure general quality of life in the study population, ranging from 0 to 100, where a zero 
score indicates the lowest level of health measured by the scales and 100 indicates the highest 
level of health. The SF-12 consists of 12 items and two dimensions, physical functioning (PCS-
12) and mental functioning (MCS-12). The 12 items scale achieved a multiple R2 of 0.911 in the 
prediction of PCS-36 and 0.918 in the prediction of MCS-36 in the general US population (n 
=2,474). The test-retest reliability estimates coefficients were 0.890 and 0.760 in PCS-12 and 
MCS-12, respectively [68]. MCS-12 was used as a measurement for mental function in 
analyzing. (Appendix D) 
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Diabetes-39 The Diabetes-Specific Health-Related Quality Of Life (Diabetes-39) was used to 
measure diabetes specific quality of life in the study population. The D-39 consists of five 
subscales, including diabetes control, anxiety and worry, social burden, sexual functioning, and 
energy and mobility. The scale of each question ranges from 1 to 7, in which 1 represents 
quality of life not affected at all, and 7 extremely affected. After standardization, the scores of 
each subscale ranges from 0 to 100, in which higher score implies worse quality of life. The 
Cronbach's alpha values from the six scales ranged from 0.81 to 0.92. [69]. The subscales of 
diabetes control, anxiety and worry, social burden were considered as covariates in model 
analyzing, since they were related to psychological traits.  (Appendix E) 
Diabetes Empowerment Scale (Short Form) (DES-SF) The diabetes empowerment scale (DES-
SF) is a brief overall assessment of diabetes related psychosocial self-efficacy. The scale ranges 
from 1 to 5, with 1 being low self-efficacy and 5 being high self-efficacy. This scale contains 
three subscales: managing the psychosocial aspects of diabetes with 9 items, assessing 
dissatisfaction and readiness to change with 9 items and setting and achieving goals with 10 
items. The scale is highly reliable (α = 0.96) [70]. (Appendix F) 
Patient Assessment of Care for Chronic Conditions (PACIC) The Patient Assessment of Care for 
Chronic Conditions (PACIC) is a brief, validated patient self-report instrument measuring 
specific actions or qualities of care that is patient-centered, proactive, planned and includes 
collaborative goal setting, problem-solving, and follow-up support[32]. The PACIC contains 20 
items, which make up five subscales. The five subscales are averaged to create a total PACIC 
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score. The five subscales consist of patient activation, delivery system design/decision support, 
goal setting, problem solving/contextual counseling, and follow up/coordination. The scale of 
each subscale and overall score is from 1 to 5, higher score indicating better response to health 
services. The PACIC demonstrated moderate test-retest reliability (r = 0.58) [32]. (Appendix G) 
2.3 STATISTICAL ANALYSIS 
The primary outcome of this study is change in the total PACIC score. Secondary outcomes 
included changes in the PACIC subscales (a) scores in patient activation; (b) scores in delivery 
system design; (c) scores in goal setting; (d) scores in problem solving and (e) scores in follow 
up. 
Primary and secondary outcomes were collected at baseline, post-DSME classes, post-
support groups (6 month time point) and post phone calls (12 month time point). The same 
anthropometric, laboratory, sociodemographic and survey variables were collected at each 
time point. Demographic and clinical data were reported using measures of central tendency 
(percentage, mean for continuous variables with normal distribution, median for countiuous 
variables with innormal distribution). All analyses were conducted as intention to treat. 
According to the principle of intention-to-teat, Last observation carried forward (LOCF) 
imputation technique was applied, in which missing values were replaced by the last observed 
value of that variable for each individual. 
Given dropout rate throughout the study, power calculations were conducted based on 
preliminary studies, using PASS 12, NCSS. Paired t-tests for continuous data and McNemar’s 
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test for categorical data were used to determine differences between those who completed 
four assessments and non-completers in demographic variables in two groups. 
In cross-sectional analyses, paired t-tests for continuous data and McNemar’s test for 
categorical data were used to determine between group differences at four time points and 
within group differences between baseline and follow-up visits. In order to examine differences 
between the study groups, a combined between and within group analysis was performed for 
each outcome of interest at each time point in mixed models adjusted for the corresponding 
baseline values. 
In longitudinal analyses, mixed models were used to analyze the change in outcome 
values throughout the study between study groups. Univariable modeling was performed 
followed by multivariable modeling. Those covariates whose p-values were < 0.20 were 
considered for multivariable models. Potential covariate variables for consideration included: 
overall DDS score (continuous), overall DES score (continuous), MCS-12 (continuous), 
D39_anxiety and worry (continuous), D39_social burden (continuous) and D39_diabetes control 
(continuous) (Table 2). A1C was also used as an effect modifier to detect whether the effect of 
peer support on outcomes differed by change in A1C. All of covariates were time-varying so 
that values at four time points of each variables were fitted into model.   
Then, the selected covariates as well as demographic variables were forced into 
multivariable model. Multicollinearity was tested among covariates. To distinguish the 
longitudinal impact of the intervention on the two study groups, a time*PACIC interaction term 
was added as a covariate in the model. The effect of study group was adjusted for the clustering 
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of patients within primary care practices and the baseline values of the corresponding 
dependent variables in all models. All data were analyzed using SAS 9.3, Cary, NC. 
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3.0 RESULTS  
3.1 DEMOGRAPHIC AND CLINICAL CHARACTERISTICS 
Demographic and clinical characteristics of participants by intervention status at baseline are 
shown in Table 3 and Table 4. There were 119 participants in the intervention group and 102 in 
the control group. Participants in the intervention group were younger (61 yr vs 64 yr, p= 
0.4883), attended at least some college or higher education (66% vs 51%, p=0.0201) and had 
lower systolic blood pressure (134.5mmHg vs. 142.7mmHg, p=0.0079), compared to 
participants in the control group. There were no significant differences between the 
intervention and the control group in the proportion of participants who were male, white, had 
type 2 diabetes, earned over $20,000 annually, used insulin, and monitored blood glucose 
status. The A1C level, low-density lipoprotein cholesterol (LDLc) and body mass index (BMI) did 
not significantly differ between the intervention and the control group on average. 
Of the initial 221 participants, 76 patients (35%) dropped out by the end of study, 46 
(39%) and 30 (30%) in the intervention and the control group, respectively (Figure 2). Given 
different dropout rates between the two groups (p=0.149), the distribution of demographic 
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characteristics  among those who completed four assessments and those who didn’t were 
tested and no significant differences were found between completers and non-completers, 
with the exception of age (Table 5). In the intervention group, completers tended to be older 
than those who dropped out during the study (p=0.02).  
3.2 CROSS-SECTIONAL ANALYSIS 
The average PACIC score in the intervention group was similar to the control group at baseline 
(2.8 vs. 2.6, p=0.39) (Table 6). In the intervention group, the average PACIC score decreased 
from 2.8 at baseline to 2.7 at post DSME assessment, but increased to 2.9 at 6 months and 
remained at this level at the end of the study. In the control group, the PACIC score increased 
by 0.2 on average at post DSME assessment and declined to 2.7 at the end of study (Figure 3). 
From baseline to post DSME assessment, PACIC score decreased by 0.1 in the intervention 
group, which was opposite with the increase of 0.2 in the control group (p=0.02). The changes 
between baseline and the other two time points were similar between the intervention and 
control groups (Table 7).  
Changes in the PACIC score between baseline and follow-up time points were 
significantly negatively associated with the baseline PACIC score. A higher baseline PACIC score 
predicted less change in the PACIC score at each of the following time points (Table 8). 
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3.3 LONGITUDINAL ANALYSIS 
Mixed models were used to evaluate the effects of the intervention on the PACIC score over 
time adjusting for relevant covariates (Table 9). In model 1, the PACIC score was not associated 
with the intervention (p=0.6), but the average within-person change in the PACIC score was 
statistically significant (p= 0.01). The PACIC score increased over time during the 12 month 
follow up. In model 2, participants with higher baseline PACIC scores were more likely to have 
higher PACIC scores during follow up (p <.0001), adjusting for intervention group and slope of 
within-person change. 
In model 3, four relevant behavioral covariates were added into model, including MCS-
12, D39-anxiety and worry subscale, DDS and DES. In the unadjusted model, MCS-12, DDS and 
DES were significantly associated with the PACIC score at each time point (Table 9). After 
adjusting for covariates, the association between the DDS score and the PACIC score was 
attenuated (p = 0.3). Results were similar to MCS-12 (p = 0.9). The average PACIC score in the 
intervention group was similar to the control group (p = 0.9), after adjusting for covariates and 
baseline PACIC score.  In model 6, age and education level were added to the model, since 
significant differences in these variables were found at baseline. The intervention group was 
not significantly different in the PACIC score than the control group with the trained diabetes 
educators.  
In model 7, the interaction term of the change in slope of the PACIC score and group 
was included in the model. The slope of the change in the PACIC score was steeper in the 
intervention group, compared to the control group (β=0.023, p=0.004).    
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Potential associations of DES, D39-anxiety and worry, MCS12 and DDS were explored to 
understand their relative contribution in the multivariate model. The results indicated that DDS 
and D39-anxiety and worry, MCS12 and D39-anxiety and worry were modestly associated 
(Table 10). In the linear regression model based on baseline values of each variable, the 
variance inflation factor (VIF) of D39-anxiety and worry was 2.5, which showed the variance of 
the coefficient estimate of D39-anxiety and worry was inflated by 2.5 times by multicollinearity 
(Table 11).   In model 3, 4 and 5 in Table 9, the reversal of the sign of the beta coefficient of the 
groups variable indicated modest multicollinearity in this multivariable model.  
3.4 SECONDARY OUTCOME  
In cross-sectional analysis, patients in the intervention group had higher scores on the patient 
activation subscales at the end of study compared to the control group (p=0.04) (Table 6). For 
the subscales patient activation, delivery system design, problem solving and follow up, the 
change in scores between baseline and other time points were consistent with total PACIC 
score, in both the intervention group and the control group. In the goal setting subscale, the 
score increased throughout the follow up period in the intervention group; while the control 
group had an increase in score at 1 month which remained at a high level until the end of the 
study (Table 7). 
In multivariate models of patient activation, delivery system design, problem-solving 
and follow-up subscales, the slope of change varied depending on group. D39-anxieity and 
worry score (p< 0.05) and DES score (p<.0001) were significantly positively associated with 
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PACIC-patient activation score and delivery system design rating, adjusting for the 
corresponding subscale score at baseline, DDS score, MCS-12, age and education level (Table 
10). 
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4.0 DISCUSSION 
4.1 SUMMARY OF FINDINGS 
This study tested the influence of peer leaders on patient-rated experience of self-management 
support in a cluster randomized trial of DSME and peer leader supported DSMS. It was assumed 
that participants in peer supported DSMS programs would have higher total PACIC scores, 
compared with those who did not receive peer supported DSMS. Compared to the control 
group, there was a steeper and continuous increase in PACIC scores throughout the study in the 
intervention group, despite the lower PACIC scores on average. PACIC scores increased with 
baseline PACIC score, but the increasing rate declined as baseline score increased. In this study, 
there was no association between the PACIC score and age or education level. However, there 
was a relationship between DES score and PACIC score. Associations were also seen in the areas 
of patient activation, delivery system design, collaborative problem solving and follow up 
subscales. 
The PACIC is a reliable instrument for measuring patients’ perceptions of the quality of 
the self-management support received. The PACIC also reliably assesses the extent to which 
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health care received aligns with the CCM[36]. Researchers have found that PACIC scores were 
significantly related to the quality of diabetes care received (i.e., patient reported blood tests 
and behavioral counseling) [36] and reported self-care behaviors [71], although few 
demographic or clinical characteristics were associated with the PACIC [36]. One study reported 
gender and education-based variability in the PACIC scores, with females and those with higher 
education levels scoring higher on the PACIC [33]. However, results from another study 
demonstrated that non-white patients and those with lower level of education were more likely 
to report that the diabetes care system was in line with the goals of the CCM [72]. All studies 
presented above were cross-sectional surveys. No other study was found that considered the 
temporal association between PACIC score and clinical outcomes, psychological outcomes and 
self-care behaviors.  
4.2 POSSIBLE EXPLANATIONS 
The success of peer support seen in the present study may be due to the reciprocal relationship 
that was created through the sharing of similar life experiences [56, 73], emotional support and 
appraisal or information supports [45], as seen in other studies. In DSME, peer leaders exert 
their influence in four respects, which are 1) assisting in self-management, 2) providing social 
and emotional support, 3) serving as a linkage to healthcare, and 4) providing ongoing support 
[58, 60]. Therefore, it is rational to explain the impact of peer support in PACIC scores based on 
these four aspects. 
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Peer leaders can help patients to reinforce and apply the concepts of DSME into their 
daily life. For instance, peer leaders can continuously work on helping patients improve self-
care behaviors after DSME through sharing reachable resources, setting applicable goals 
together, practicing and rehearsing of behaviors, trouble-shooting barriers and problem 
solving[58]. In this study, compared to the control group, patients in the intervention group 
may have received more flexible, non-threatening, timely support from their peer leaders, 
which may explain better feedback in quality of management care they received.  
The potential mechanistic model for peer leaders from Heisler et. al. implies that peer 
support was beneficial in promoting motivation, increasing positive mood and understanding, 
dealing with diabetes-specific distress and building up an extensive social network [45, 56]. In 
addition, the finding that patients with chronic disease attained benefits from peer support 
programs when used as a means of improving psychosocial outcomes was documented widely 
in the literature [74, 75]. Other studies supported the relationship between psychological 
outcomes and patient satisfaction [76, 77]. In SEED, peer leaders spent more time in supportive 
interaction with patients, generally including attentive listening, encouragement and 
reassurance, compared to routine counsel from diabetes educators. Emotional support from 
peers may foster the experience of feeling accepted, cared for, admired, empathized, respected 
and valued, thus alleviating distress and depression and positively impacting PACIC scores[56]. 
Meanwhile, peer involvement may facilitate communication between patients and 
health care professions and construct more effective visits that focus on making informed self-
management decisions and achieving personal self-care goals.  In the intervention group, the 
peer leader may have had more opportunities for participants to discuss self-management 
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barriers and goals, and to talk about upcoming physician appointments during the follow up 
period, compared with support provided by diabetes educators in the control group. The 
connections between participants and members of the health care team which involved peer 
leaders could have a positive influence on patients’ responses to certain questions in PACIC, 
such as “Asked how my visits with other doctors were going” or “Told how my visits with other 
types of doctors, like an eye doctor or other specialist, helped my treatment”.  
4.3 LIMITATIONS 
This study had limitations that are worth consideration. First, the relatively small sample size 
(n=221) may lead to failure in detecting significant differences between the intervention and 
the control group and may explain the decreasing then increasing trend in the PACIC score. The 
results of power calculation were shown in Table 13. Setting the significance level at 0.05, the 
variance of random effect matrix as 0.15, and a residual variance as 0.35 based on the above 
data and results, to detect the size effect of 0.1 between intervention and control group, the 
present sample size can only gained approximately 29% power.  
Additionally, the dropout rates were 39% in the intervention group and 30% in the 
control group, which may have overestimated the relationship between PACIC and 
intervention, because the higher dropout rate in intervention group may have resulted from 
lack of confidence in the information and support offered by peer leaders rather than the 
professionals. The difference in age between the groups implied that those who dropped out in 
the intervention group tended to be younger, which may have also biased results. 
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Third, variability in the patients’ ability to interpret survey questions across literacy 
levels may have resulted in reporting bias, although this study reported little association 
between education level and survey score. In addition, social desirability bias cannot be ignored 
when explaining these survey data. Patients may tend to provide more positive feedback to 
peers given the frequency of communication.  
Moreover, due to lack of information about established confounders for the PACIC, the 
impact of the intervention was less convincing without adjusting for the effects of potential 
confounders. 
Finally, the fidelity of intervention may be a limitation in this trial. Although all peer 
leaders received training before study and received follow-up support from the diabetes 
educators, the effects of intervention may vary depending on the personality, literacy level and 
the enthusiasm of the peer and the collaboration with patients. Moreover, there was also lack 
of formally monitoring of intervention fidelity to determine if it was administered as intended.  
4.4 SIGNIFICANCE OF STUDY 
Optimizing outcomes among patients with diabetes requires an engaged, competent patient 
receiving the most effective care, treatment and support [35]. It is a priority to encourage 
active patient participation in care, including an active role in defining and reforming their 
chronic disease management. Few studies exist evaluating if peer support programs assessed 
the overall quality of diabetes care delivered in primary care settings from the patient 
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perspective. This study provided a patient-centered approach to assess the quality of service in 
a peer led DSMS program.  
This study explored the possible temporal association between PACIC scores and 
intervention with peer leaders, which may be considered as complementary evidence to 
support the mechanisms by which peer support may lead to improved or equal outcomes. 
Moreover, given limited health resources, this study examined an approach that can make 
greater use of community resources to gain equal effectiveness with lower cost. 
4.5 FUTURE STUDIES 
Based on our findings, the PACIC score was related to certain psychological variables such as 
diabetes-related distress or empowerment. Yet, relatively little is known about how robust 
these relationships may be. It is possible that patients with diabetes distress are less likely to 
receive disease management or be satisfied with the health care they receive. Thus in future 
studies, it is necessary to examine the effect of distress on PACIC scores in studies considering 
factors associated with diabetes care.  
In the analysis of PACIC subscales, there was a positive association between the degree 
of anxiety and patient activation and delivery system design scores. Further explanations for 
these correlations are needed.  
This study found a potential association between baseline PACIC scores and the pattern 
of changes in the PACIC score over time. It was a rational assumption that a benign interaction 
between patients and health care team, such as sharing responsibility for management and 
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sharing control of clinical interactions and decisions could have continuous and accumulated 
influence in patient satisfaction but the degree of that increase would decrease with higher 
levels of satisfaction at baseline. Thus, more studies exploring patients characteristics at the 
start of DSME and DSMS may help to target populations who need more support where may 
yield more effective and efficient healthcare management in the future. 
4.6 PUBLIC HEALTH SIGNIFICANCE  
With the growing prevalence of diabetes and shortage of diabetes educators, it is increasingly 
important to integrate and utilize low-cost interventions in high-risk communities that build on 
available resources. Using peers is promising to optimize DSME and DSMS to meet increasing 
demands from patients. Interventions supported by trained peers are much less resource 
intensive than current care models, since peers are an important component of existing 
community sources. Additionally, peer support may have a positive impact in optimizing health 
care delivery and addressing psychosocial aspects of chronic conditions and hence self-
management. 
The involvement of peer leaders expands the boundary and depth of DSME and DSMS, 
and makes it possible to reach more and more patients with diabetes, especially in a health 
care system facing severe resource constraints. 
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Figure 1 Flowchart of Study Process in the SEED Project 
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Table 1 Available measurements in the SEED Project* 
 Measures Method Expected change with intervention 
Clinical characteristic  
 A1C (%) Quest Labs % of subjects with A1c<7% ↑ 
Mean A1c values↓ 
 LDLc(mg/dL) Quest Labs % of subjects with LDLc < 100 mg/dL ↑ 
 Blood Pressure (mmHg) HDFP protocol % of subjects with BP< 130/80mmHg ↑ 
 Weight (lbs)  Average values ↓ 
 Height (inches)  - 
 BMI(kg/m2) Calculated based on 
weight and height 
% of subjects with BMI in 25-30 kg/m2↓ 
% of subjects with BMI in 30-40 kg/m2↓ 
 Triglyceride (mg/dL)   Quest Labs Average values ↓ 
 Total Cholesterol (mg/dL) Quest Labs Average values ↓ 
Survey data 
 DDS Self-report  Average score ↓ 
 SF-12 Self-report  Average score in MCS and PCS ↑ 
 Diabetes-39 Self-report  Average score in five subscales↓ 
 DES-SF Self-report  Average score ↑ 
 PACIC Self-report  Average score ↑ 
A1C: Glycosylated Hemoglobin 
HDFP: Hypertension Detection and Follow-Up program 
BMI: Body mass index 
LDL: Low-Density Lipoprotein 
DDS: Diabetes Distress Scale 
SF-12: 12-item Short Form Health Survey 
Diabetes-39: The Diabetes-Specific Health-Related Quality Of Life 
DES-SF: Diabetes Empowerment Scale (Short Form) 
PACIC: Patient Assessment of Care for Chronic Conditions  
SEED: Support, Education, and Evaluation in Diabetes 
*All measurements were examined at four time points. 
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Table 2 Selection of covariates for the final mixed model for PACIC score in the SEED project 
 Covariate* Coefficient Estimate P-Value 
PACIC_total DDS -0.2215 <.0001 
 DES 0.3748 <.0001 
 MCS-12 0.01069 0.0023 
 D39_AW -0.00256 0.0897 
 D39_SB 0.1362 0.8044 
 D39_DC -0.00191 0.2492 
 A1C -0.01771 0.5719 
PACIC: Patient Assessment of Care for Chronic Conditions  
DDS: Diabetes Distress Scale 
DES: Diabetes Empowerment Scale (Short Form) 
MCS-12: Mental health component scale 
D39_AW: Anxiety and worry subscale in Diabetes-39 
D39_SB: Social burden subscale in Diabetes-39 
D39_DC: Diabetes control subscale in Diabetes-39 
*Mixed models were used for test, where total PACIC score for were dependent variables, and each 
values of covariates at four time points were independent variables. 
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Table 3 Sociodemographic Characteristics of Participants in the SEED project at Baseline 
Demographic Characteristics Overall Intervention Control p-value* 
Total  221 119 102 - 
Gender     
   Female, N (%) 142(64.3) 74(61.9) 68(66.7) 0.4883 
Ethnicity      
 White, N (%) 210 (95.0) 113 (95.0) 97(95.1) 0.9619 
Age(yr)     
 Mean (SD) 62.9(10.8) 61.3 (11.5) 64.7 (10.7) 0.0237 
Type of diabetes      
 Type 2 diabetes, N (%) 189 (85.52) 104(87.4) 85 (83.3) 0.8357 
Education level     
 College or higher, N (%) 131 (59.3) 79 (66.4) 52(51.0) 0.0201 
 High school or lower, N (%) 90 (40.7) 40(33.6) 50(49.0)  
Income     
 <$20,000, N (%) 65(31.0) 35 (30.2) 30(31.9) 0.7859 
 ≥$20,000, N (%) 145 (69.1) 81 (69.8) 64(68.1)  
 Missing value  11 3 8  
Blood glucose monitor     
 Yes, N (%) 174 (79.1) 90 (76.3) 84(82.4) 0.2686 
 No, N (%) 46 (20.9) 28 (23.7) 18(17.7)  
 Missing value 1 1 0  
Insulin use     
 Yes, N (%) 66 (30.3) 38(32.8) 28(27.5) 0.3947 
 No, N (%) 152 (69.7) 78(67.8) 74(72.6)  
 Missing value 3 3 0  
SD: standard deviation  
SEED: Support, Education, and Evaluation in Diabetes project 
* Chi-square test were used for categorical variables; t-test was used for continuous variables. 
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Table 4 Clinical Characteristics of Participants in the SEED project at Baseline 
Clinical Outcome Profile Overall Intervention Control p-value* 
Total  217 115 102 - 
A1C (%)     
   Mean(SD) 7.5 (1.6) 7.6(1.7) 7.4(1.4) 0.6262 
 Median 7.1 7.0 7.1  
 <7%, N (%) 90(47.1) 49(46.7) 41(47.7) 0.8896 
 ≥7%, N (%) 101(52.9) 56(53.3) 45(52.3)  
 Missing value 26 10 16  
LDL (mg/dL)     
   Mean(SD) 98.4(31.3) 95.8(27.9) 101.2(34.6) 0.2534 
 <100, N (%) 102(56.7) 56(59.6) 46(53.5) 0.4105 
 ≥100, N (%) 78(43.3) 38(40.4) 40(46.5)  
 Missing value 37 21 16  
SBP(mmHg)     
 Mean(SD) 138.3(18.0) 134.5(15.6) 142.7(19.6) 0.0079 
 Median  136.0 135.0 136.8  
 <140mmHg, N (%) 126(58.6) 72(62.6) 54(54.0) 0.2012 
 ≥140 mmHg, N (%) 89(41.4) 43(37.4) 46(46.0)  
 Missing value 2 0 2  
DBP(mmHg)     
 Mean(SD) 76.6(9.6) 75.6(9.5) 77.8 (9.6) 0.0920 
 Median  78.0 77.0 79.8  
 <80 mmHg, N (%) 121(56.3) 71(61.7) 50(50.0) 0.0835 
 ≥80 mmHg, N (%) 94(43.7) 44(38.3) 50(50.0)  
 Missing value 2 0 2  
BMI     
 Mean(SD) 34.9(7.3) 35.5(7.7) 34.3(6.8) 0.2029 
 Median 33.7 33.8 32.8  
 <25, N (%) 12(5.6) 6(5.2) 6(5.9) 0.8526 
 ≥25 and <30, N (%) 44(20.4) 22(19.1) 22(21.8)  
 ≥30, N (%) 160(74.1) 87(75.7) 73(72.3)  
 Missing value 1 0 1  
A1C: Glycosylated Hemoglobin 
LDL: Low-Density Lipoprotein 
SBP: Systolic Blood Pressure 
DBP: Diastolic Blood Pressure 
BMI: Body mass index 
* Chi-square test were used for categorical variables; t-test was used for continuous variables. 
SEED: Support, Education, and Evaluation in Diabetes project 
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           SEED: Support, Education, and Evaluation in Diabetes project 
 
 
 
 
 
 
Post DSME (n=185) 
• Intervention: n=96 (80%) 
• Control: n=89 (87%) 
6 months (n=152) 
• Intervention: n=79 (66%) 
• Control: n=73 (71%) 
12 months (n=145) 
• Intervention: n=73 (61%) 
• Control: n=72 (70%) 
Baseline (n=221) 
• Intervention: n=119 
• Control: n=102 
Withdraw (n=36) 
• Intervention (n=23) 
• Control (n=13) 
Withdraw (n=33) 
• Intervention (n=17) 
• Control (n=16) 
Withdraw (n=7) 
• Intervention (n=6) 
• Control (n=1) 
Figure 2 Flowchart of Participants in the SEED project 
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Table 5 Comparison of Demographic Characteristics between completers and non-completers 
in the two study groups In the SEED project 
Time points Group Completers  Non-completers p-value** 
Female, N(%) Intervention 41 (56.1%) 33 (71.7%) 0.08 
Control  46 (63.9%) 22 (73.3%) 0.35 
White, N(%) * Intervention 67 (91.8%) 46 (100%) 0.08 
Control  28 (93.3%) 69 (95.8%) 0.62 
College or higher 
education, N (%) 
Intervention 67(69.8%) 27 (58.7%) 0.15 
Control  38 (52.8%) 14 (46.7%) 0.57 
Income>=$20,000,  
N (%) 
Intervention 51(72.9%) 30 (65.2%) 0.38 
Control  48 (72.7%) 16 (57.1%) 0.14 
Age, Mean (SD) Intervention 63.2 (10.4) 58.3 (12.4) 0.02 
Control  65.8 (9.9) 61.8 (11.9)             0.08 
*Fish’s exact test was used; 
**Chi-square test were used for categorical variables, except for ethnicity; t-test was used for continuous 
variables. 
SEED: Support, Education, and Evaluation in Diabetes project 
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Table 6 Comparisons of mean scores of PACIC and its subscales between two groups at four 
time points in the SEED project 
Scales Visit Intervention Mean(SD) 
Control 
Mean(SD) p-value* 
Coefficient 
estimateⱡ 
PACIC_total Baseline 2.76(1.11) 2.63(1.06) 0.3939 0.1280 
Visit 1 2.69(1.07) 2.85(1.07) 0.2868 -0.1558 
Visit 2 2.94(1.17) 2.86(1.11) 0.6175 0.07781 
Visit 3 2.95(1.15) 2.71(1.11) 0.1295 0.2350 
Patient Activation Baseline 2.88(1.31) 2.70(1.23) 0.3184 0.1736 
Visit 1 2.69(1.22) 2.75(1.22) 0.7454 -0.05389 
Visit 2 2.94(1.32) 2.86(1.32) 0.6709 0.07671 
Visit 3 3.04(1.28) 2.68(1.33) 0.0488 0.3521* 
Delivery System 
Design 
Baseline 2.94(1.18) 2.79(1.14) 0.3928 0.1369 
Visit 1 2.83(1.14) 2.96(1.19) 0.4319 -0.1247 
Visit 2 3.05(1.22) 2.94(1.13) 0.4874 0.1120 
Visit 3 3.11(1.19) 2.85(1.15) 0.1095 0.2572 
Goal Setting Baseline 2.64(1.30) 2.51(1.13) 0.4386 0.1294 
Visit 1 2.66(1.18) 2.82(1.13) 0.3268 -0.1548 
Visit 2 2.91(1.26) 2.83(1.15) 0.6127 0.08335 
Visit 3 2.86(1.24) 2.71(1.18) 0.3629 0.1501 
Problem-solving Baseline 2.70(1.32) 2.61(1.37) 0.5886 0.1001 
Visit 1 2.60(1.30) 2.85(1.31) 0.1616 -0.2507 
Visit 2 2.93(1.36) 2.88(1.39) 0.7579 0.05777 
Visit 3 2.91(1.35) 2.69(1.36) 0.2094 0.2329 
Follow-up Baseline 2.73(1.15) 2.58(1.10) 0.3318 0.1508 
Visit 1 2.69(1.12) 2.83(1.11) 0.3754 -0.1357 
Visit 2 2.90(1.21) 2.85(1.20) 0.7103 0.06138 
Visit 3 2.88(1.21) 2.66(1.15) 0.1575 0.2284 
*p-value<0.05 
ⱡ: The control group as reference group 
Visit 1: post DSME assessment at 1 month 
Visit 2: post supports group assessment at 6 months 
Visit 3: post phone calls assessment at 12 months 
PACIC: Patient Assessment of Care for Chronic Conditions  
*Mixed models at specific time points were used  
SEED: Support, Education, and Evaluation in Diabetes project 
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Figure 3 Trends of mean PACIC Scores over Time in the Intervention and the Control Group in 
the SEED project 
PACIC: Patient Assessment of Care for Chronic Conditions  
SEED: Support, Education, and Evaluation in Diabetes project 
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baseline visit 1 visit 2 visit 3
PACIC score at four time points 
Control Intervention
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Table 7 Relationship of groups and average change between baselines and subsequent time 
points for PACIC and the subscales in the SEED project 
Scales Pair of time points 
Intervention 
Mean(SD) 
Control 
Mean(SD) p-value** 
Coefficient 
estimateⱡ 
PACIC_total 
V1 vs. Baseline -0.07 (0.72) 0.22 (0.92) 0.0204 -0.2399* 
V2 vs. Baseline 0.18 (0.82) 0.24 (0.97) 0.8967 -0.0149 
V3 vs. baseline 0.19 (0.75) 0.08 (1.00) 0.1724 0.1551 
Patient 
Activation 
V1 vs. Baseline -0.17(1.04) 0.04(1.03) 0.2078 -0.1609 
V2 vs. Baseline 0.07(1.07) 0.15(1.11) 0.8454 -0.02701 
V3 vs. baseline 0.17(1.06) -0.02(1.21) 0.0594 0.2678 
Delivery 
System Design 
V1 vs. Baseline -0.11(0.92) 0.17 (1.07) 0.0829 -0.2143 
V2 vs. Baseline 0.10(0.91) 0.14(1.08) 0.9226 0.01208 
V3 vs. baseline 0.17(0.91) 0.05(1.05) 0.1828 0.1628 
Goal Setting 
V1 vs. Baseline 0.01(0.93) 0.32(1.05) 0.0398 -0.2468* 
V2 vs. Baseline 0.28(1.03) 0.32(1.10) 0.9317 0.01123 
V3 vs. baseline 0.23(0.91) 0.20(1.10) 0.5681 0.07207 
Problem 
-solving 
V1 vs. Baseline -0.11(1.03) 0.25(1.24) 0.0333 -0.2983* 
V2 vs. Baseline 0.24(1.10) 0.28(1.24) 0.9368 -0.01167 
V3 vs. baseline 0.22(1.07) 0.10(1.35) 0.2499 0.1732 
Follow-up 
V1 vs. Baseline -0.03(0.78) 0.26(1.03) 0.0477 -0.2245* 
V2 vs. Baseline 0.17(0.90) 0.28(1.14) 0.7639 -0.03961 
V3 vs. baseline 0.15(0.87) 0.07(1.08) 0.2266 0.1512 
*p<0.05 
**Mixed models were used, where difference between baseline and other time points were used as 
dependent variable. 
ⱡ: The control group as reference group; this model included baseline PACIC score as covariate. 
Visit 1: post DSME assessment at 1 month 
Visit 2: post supports group assessment at 6 months 
Visit 3: post phone calls assessment at 12 months 
PACIC: Patient Assessment of Care for Chronic Conditions  
SEED: Support, Education, and Evaluation in Diabetes project 
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Table 8 Relationship of baseline scores and average change between baseline and each 
subsequent time point for PACIC and its subscales in the SEED project 
Scales Pair of time points Intercept Coefficient estimateⱡ p-value 
PACIC_total 
V1 vs. Baseline 0.8177 -0.2864 <.0001 
V2 vs. Baseline 0.9936 -0.2860 <.0001 
V3 vs. baseline 0.9656 -0.2808 <.0001 
Patient Activation 
V1 vs. Baseline 1.0422 -0.3680 <.0001 
V2 vs. Baseline 1.0460 -0.3276 <.0001 
V3 vs. baseline 1.0038 -0.3789 <.0001 
Delivery System 
Design 
V1 vs. Baseline 1.1763 -0.3668 <.0001 
V2 vs. Baseline 1.1151 -0.3465 <.0001 
V3 vs. baseline 1.0058 -0.3393 <.0001 
Goal Setting 
V1 vs. Baseline 1.2594 -0.3754 <.0001 
V2 vs. Baseline 1.3029 -0.3890 <.0001 
V3 vs. baseline 1.0758 -0.3452 <.0001 
Problem-solving 
V1 vs. Baseline 1.2031 -0.3705 <.0001 
V2 vs. Baseline 1.2094 -0.3530 <.0001 
V3 vs. baseline 1.1231 -0.3940 <.0001 
Follow-up 
V1 vs. Baseline 1.0104 -0.2980 <.0001 
V2 vs. Baseline 1.1098 -0.3255 <.0001 
V3 vs. baseline 0.8499 -0.3059 <.0001 
ⱡ: The mixed model included the intervention term as a covariate; the dependent variable was the 
changes in the PACIC score between baseline and the subsequent time point. 
Visit 1: post DSME assessment at 1 month 
Visit 2: post support group assessment at 6 months 
Visit 3: post phone calls assessment at 12 months 
PACIC: Patient Assessment of Care for Chronic Conditions  
SEED: Support, Education, and Evaluation in Diabetes project 
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Table 9 Estimated Coefficients of Covariates in The Mixed models of PACIC score and other covariates in the SEED project 
Variables Model 1 Model 2 Model 3 Model 4 Model 5 Model 6 Model 7 Model 8 Model 9 
Intercept 2.713** 0.650** -0.300 -0.417 -0.177 -0.100 -0.032 -0.159 0.169 
Group∆ 0.069 -0.027 -0.001 0.005 0.015 -0.006 -0.119 -0.117 -0.113 
Within-person change slope 0.011* 0.011* 0.011* 0.011* 0.011* 0.011* -0.001 -0.001 -0.001 
Baseline of PACIC - 0.783** 0.712** 0.719** 0.722** 0.710** 0.709** 0.712** 0.713** 
DDS - - -0.042 - -0.015 -0.043 -0.047 - -0.020 
DES - - 0.294** 0.300** 0.286** 0.295** 0.295** 0.305** 0.292** 
MCS12 - - -0.000 0.000 -0.002 -0.000 -0.000 -0.000 -0.002 
D39_Anxiety and worry - - 0.002 0.002 - 0.002 0.002 0.001 - 
Age - - - - - -0.003 -0.003 -0.003 -0.004 
Educationⱡ - - - - - 0.009 0.009 0.013 0.006 
Slope*group - - - - - - 0.023* 0.023* 0.023* 
AIC 2113.2 1811.0 1745.1 1747.0 1744.1 1744.5 1744.2 1741.0 1736.7 
PACIC: Patient Assessment of Care for Chronic Conditions  
DDS: Diabetes Distress Scale 
DES: Diabetes Empowerment Scale (Short Form) 
MCS-12: Mental health component scale 
D39_AW: Anxiety and worry subscale in Diabetes-39 
AIC: Akaike Information Criteria 
* P-value<0.05 
** P-value<0.0001 
∆: The control group as reference group; 
ⱡ: Attending high school or lower group as reference group 
SEED: Support, Education, and Evaluation in Diabetes project 
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Table 10 The Pearson Correlation Coefficients Between Covariates In The Multivariable 
Model* 
 PACIC DES DDS D39_AW MCS12 
PACIC 1.00     
DES 0.34 1.00    
DDS -0.18 -0.33 1.00   
D39_AW -0.09 -0.28 0.68 1.00  
MCS12 0.15 0.24 -0.51 -0.66 1.00 
PACIC: Patient Assessment of Care for Chronic Conditions  
DDS: Diabetes Distress Scale 
DES: Diabetes Empowerment Scale (Short Form) 
MCS-12: Mental health component scale 
D39_AW: Anxiety and worry subscale in Diabetes-39 
*Only baseline values of covariates were used. 
 
 
 
Table 11 Variance inflation factor of covariates in multivariable model in the SEED project* 
Variable Parameter estimates Standard Errors  t Value Pr > |t| VIF 
Intercept 0.362 0.65984 0.55 0.5839 0 
DES 0.47579 0.10375 4.59 <.0001 1.16429 
DDS -0.1111 0.10454 -1.06 0.2892 1.99503 
D39_aw 0.00634 0.00382 1.66 0.0985 2.52431 
MCS12 0.01087 0.0081 1.34 0.1814 1.79566 
PACIC: Patient Assessment of Care for Chronic Conditions  
DDS: Diabetes Distress Scale 
DES: Diabetes Empowerment Scale (Short Form) 
MCS-12: Mental health component scale 
D39_AW: Anxiety and worry subscale in Diabetes-39 
VIF: variance inflation factor 
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Table 12 Estimated Coefficients of Covariates in The Mixed models of subscales of PACIC and other covariates in the SEED project 
Variables Patient Activation 
Delivery System 
Design Goal Setting Problem-solving Follow-up 
Intercept 0.108 0.062 -0.146 0.251 0.101 
Group∆ -0.114 -0.123 -0.096 -0.153 -0.099 
Within-person change slope -0.005 -0.003 0.006 -0.000 -0.002 
Baseline value of each subscales 0.679** 0.674** 0.656 ** 0.654 ** 0.691 ** 
DDS -0.055 -0.083 -0.029 -0.069 -0.022 
DES 0.222** 0.252** 0.322 ** 0.343 ** 0.314 ** 
MCS12 0.005 0.003 -0.000 -0.000 -0.005 
D39_Anxiety and worry 0.004* 0.005* 0.002 0.002 0.0002 
Age -0.005 -0.003 -0.002 -0.006 -0.001 
Educationⱡ 0.018 0.018 0.068 -0.035 -0.004 
Slope*group 0.028* 0.023* 0.018 0.027* 0.019* 
PACIC: Patient Assessment of Care for Chronic Conditions  
DDS: Diabetes Distress Scale 
DES: Diabetes Empowerment Scale (Short Form) 
MCS-12: Mental health component scale 
D39_AW: Anxiety and worry subscale in Diabetes-39 
AIC: Akaike Information Criteria 
* P-value<0.05 
** P-value<0.0001 
∆: The control group as reference group; 
ⱡ: Attending high school or lower group as reference group 
SEED: Support, Education, and Evaluation in Diabetes project 
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Table 13 Power calculation in the SEED project 
Size effect 
Within subject  Between subjects 
N=200 N=240 N=200 N=240 
0.1 28% 38% 29% 41% 
0.15 58% 65% 62% 66% 
0.2 77% 86% 90% 88% 
0.3 100% 99% 100% 100% 
N: total number of subjects in two groups 
Size effect: the minimum detectable difference of PACIC score 
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APPENDIX A: THE CONTACT LOG IN THE SEED PROJECT 
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APPENDIX B: THE LAB REQUISITION FORM IN THE SEED PROJECT 
 
 
54 
 
APPENDIX C: DIABETES DISTRESS SCALES 
Source: Polonski, W.H., Fisher, L., Earles, J., Dudley, R.J., Lees, J., Mullan, J.T. & Jackson, R.A. (2005). 
Assessing psychological stress in diabetes. Diabetes Care. 28,  626 – 631. 
 
THE DIABETES DISTRESS SCREENING SCALE 
 
 
 
 
 
 
DIRECTIONS:  Living with diabetes can sometimes be tough.  There may be many problems 
and hassles concerning diabetes and they can vary greatly in severity.  Problems may range from 
minor hassles to major life difficulties.  Listed below are 2 potential problem areas that 
people with diabetes may experience.  Consider the degree to which each of the 2 items may 
have distressed or bothered you DURING THE PAST MONTH and circle the appropriate number. 
 
Please note that we are asking you to indicate the degree to which each item may be 
bothering you in your life, NOT whether the item is merely true for you.  If you feel that a 
particular item is not a bother or a problem for you, you would circle "1".   If it is very 
bothersome to you, you might circle "6". 
 
 
 
 
 
 
  
Not a 
Problem 
 
A Slight 
Problem 
A 
Moderate 
Problem 
Somewhat 
Serious 
Problem 
 
A Serious 
Problem 
A Very 
Serious 
Problem 
 
1.  Feeling overwhelmed by the 
demands of living with diabetes. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
2.  Feeling that I am often failing 
with my diabetes routine. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
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DDS 
 
 
DIRECTIONS:  Living with diabetes can sometimes be tough.  There may be many problems 
and hassles concerning diabetes and they can vary greatly in severity.  Problems may range from 
minor hassles to major life difficulties.  Listed below are 17 potential problem areas that people 
with diabetes may experience.  Consider the degree to which each of the 17 items may have 
distressed or bothered you DURING THE PAST MONTH and circle the appropriate number. 
 
Please note that we are asking you to indicate the degree to which each item may be 
bothering you in your life, NOT whether the item is merely true for you.  If you feel that a 
particular item is not a bother or a problem for you, you would circle "1".   If it is very 
bothersome to you, you might circle "6". 
 
 
  
Not a 
Problem 
 
A Slight 
Problem 
A 
Moderate 
Problem 
Somewhat 
Serious 
Problem 
 
A Serious 
Problem 
A Very 
Serious 
Problem 
1. Feeling that diabetes is taking 
up too much of my mental and 
physical energy every day. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
2. Feeling that my doctor 
doesn't know enough about 
diabetes and diabetes care. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
3. Feeling angry, scared, and/or 
depressed when I think about 
living with diabetes. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
4. Feeling that my doctor doesn't 
give me clear enough directions on 
how to manage my diabetes. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
 
5. Feeling that I am not testing my 
blood sugars frequently enough. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
6.  Feeling that I am often failing 
with my diabetes routine. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
7. Feeling that friends or family 
are not supportive enough of 
self-care efforts (e.g. planning 
activities that conflict with my 
schedule, encouraging me to 
eat the "wrong" foods). 
 
 
 
1 
 
 
 
2 
 
 
 
3 
 
 
 
4 
 
 
 
5 
 
 
 
6 
 
8. Feeling that diabetes controls 
my life. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
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Not a 
Problem 
 
A Slight 
Problem 
A 
Moderate 
Problem 
Somewhat 
Serious 
Problem 
 
A Serious 
Problem 
A Very 
Serious 
Problem 
9. Feeling that my doctor 
doesn't take my concerns 
seriously enough. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
10. Not feeling confident in my 
day-to-day ability to manage 
diabetes. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
11. Feeling that I will end up with 
serious long-term complications, 
no matter what I do. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
12. Feeling that I am not sticking 
closely enough to a good meal 
plan. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
13. Feeling that friends or family 
don't appreciate how difficult 
living with diabetes can be. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
 
14. Feeling overwhelmed by the 
demands of living with diabetes. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
15. Feeling that I don't have a 
doctor who I can see regularly 
enough about my diabetes. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
16. Not feeling motivated to keep 
up my diabetes self 
management  
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
17. Feeling that friends or family 
don't give me the emotional 
support that I would like. 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
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DDS17 SCORING SHEET 
 
 
 
 
INSTRUCTIONS FOR SCORING: 
 
The DDS17 yields a total diabetes distress scale score plus 4 sub scale scores, each 
addressing a different kind of distress. To score, simply sum the patient’s responses to the 
appropriate items and divide by the number of items in that scale. The letter in the far right margin 
corresponds to that item’s subscale as listed below.  We consider a mean item score of 3 or higher 
(moderate distress) as a level of distress worthy of clinical attention.  Place a check on the line to 
the far right if the mean item score is ≥ 3 to highlight an above-range value. 
 
We also suggest reviewing the patient’s responses across all items, regardless of mean item 
scores.  It may be helpful to inquire further or to begin a conversation about any single item scored 
3 or higher. 
 
 
 
Total DDS Score: 
 
 
a. Sum of 17 item scores. 
b. Divide by: 
c. Mean item score: 
 
 
 
17 
   ≥ 3    
 
A. Emotional Burden: 
 
 
a. Sum of 5 items (1, 3, 8, 11, 14) 
b. Divide by: 
c. Mean item score: 
 
 
 
5 
   ≥ 3    
 
B. Physician-related Distress: 
a. Sum of 4 items (2, 4, 9, 15) 
b. Divide by: 
c. Mean item score: 
 
 
 
4 
  ≥ 3    
 
C. Regimen-related Distress: 
a. Sum of 5 items (5, 6, 10, 12, 16) 
b. Divide by: 
c. Mean item score: 
 
 
 
5 
  ≥ 3   
D. Interpersonal Distress: 
a.   Sum of 3 items (7, 13, 17) 
b.   Divide by: 
c.   Mean item score: 
 
 
 
3 
  ≥ 3   
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APPENDIX D: SF-12v1® HEALTH SURVEY 
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SF-12 Health Survey 
 
Answer every question by selecting the answer as indicated. If you are unsure 
about how to answer a question, please give the best answer you can. 
 
 
1. In general, would you say your health is: 
 
Excellent Very 
good 
 
 
 
Good Fair Poor 
 
 
 
 
 
The following questions are about activities you might do during a typical day. Does 
your health now limit you in these activities? If so, how much? 
 
 
 
 
 
2. Moderate activities, such as moving a table, pushing a 
vacuum cleaner, bowling, or playing golf 
 
3. Climbing several flights of stairs 
Yes, 
limited 
a lot 
Yes, 
limited 
a little 
No, not 
limited 
at all 
 
 
 
During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of your physical health? 
 
 
 
4. Accomplished less than you would like 
 
5. Were limited in the kind of work or other activities 
Yes No 
 
 
 
During the past 4 weeks, have you had any of the following problems with your work or 
other regular daily activities as a result of any emotional problems (such as feeling 
depressed or anxious)? 
 
 
 
6. Accomplished less than you would like 
 
7. Didn't do work or other activities as carefully as usual 
Yes No 
 
 
 
8. During the past 4 weeks, how much did pain interfere with your normal work 
(including both work outside the home and housework)? 
 
Not at all A little Moderately Quite a Extremely 
 60 
bit bit 
 
 
 
 
 
These questions are about how you feel and how things have been with you during 
the past 4 weeks. For each question, please give the one answer that comes closest 
to the way you have been feeling. 
 
How much of the time during the past 4 weeks... 
 
 
 
 
 
9. Have you felt calm and 
peaceful? 
10. Did you have a lot of 
energy? 
11. Have you felt 
downhearted and 
blue? 
All of 
the 
time 
 
Most of 
the time 
A Good 
Bit of 
the Time 
 
Some of 
the time 
 
A little of 
the time 
 
None of 
the time 
 
 
 
12. During the past 4 weeks, how much of the time has your physical health or 
emotional problems interfered with your social activities (like visiting friends, relatives, 
etc.)? 
 
All of 
the time 
 
Most of 
the time 
Some of 
the time 
A little of 
the time 
None of 
the time 
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APPENDIX E: DIABETES-SPECIFIC HEALTH-RELATED QUALITY OF LIFE (DIABETES-39) 
Source: Boyer Jg, Earp Ja. The Development of an Instrument for Assessing the Quality Of Life 
of People with Diabetes: Diabetes-39. Med Care 1997;35:440-53. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Diabetes-Specific Health-Related Quality of Life (Diabetes-39)   
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This questionnaire is designed to help us to learn more about what affects the quality of 
life of people with diabetes. 
 
 
How to complete this questionnaire? 
 
• For each of the following questions, we want to know how much your quality of life 
has been affected. Please answer the questions by putting a cross (Х) somewhere 
on the line following each question. 
 
• The line starts at number 1 and a cross here means that your quality of life has not 
been affected at all. The line ends at number 7 and a cross here means that your 
quality of life has been extremely affected. Place your cross on the line at the point 
which you think best describes how you quality of life has been affected in the past 
month. 
 
• It is very important that you answer  every question. However, some of the 
questions which ask about your personal life may not be applicable to you. Please 
leave them and go on to the next question. All replies will be treated in confidence. 
 
• Example: 
► If you thought “air pollution” affected your quality of life to some extent, but 
not extremely, you might mark the line as shown below. 
 
 
During the past month, how much was the quality of your life affected by: 
 
Q1. Air pollution 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
► If you were to answer the same question, where would you put your cross? 
If you think you have been more affected by air pollution in the past month than 
the person in the above example, you should place your cross somewhere to the 
right of the existing cross. However, if you think you have been less affected, 
then your cross should be placed somewhere to the left of the existing cross. To 
practice, please put your cross on the line. 
 
During the past month, how much was the quality of your life affected by:  
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Q1. your daily medication for your diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q2. worries about money matters 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q3. limited energy levels 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q4. following your doctor’s prescribed treatment plan for diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q5. food restrictions required to control your diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q6. concerns about your future 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
Q7. other health problems besides diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
During the past month, how much was the quality of your life affected by:  
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Q8. stress or pressure in your life 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q9. feelings of weakness 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q10. restrictions on how far you can walk 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q11. any daily exercises for your diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q12. loss or blurring of version 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q13. not being able to do what you want 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
Q14. having diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
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Q15. losing control of your blood sugar levels 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q16. other illnesses besides diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q17. testing your blood sugar levels 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q18. the time required to control your diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q19. the restrictions your diabetes places on your family and friends 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q20. being embarrassed because you have diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q21. diabetes interfering with your sex life 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
During the past month, how much was the quality of your life affected by:  
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Q22. feeling depressed or low 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q23. problems with sexual functioning 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q24. getting your diabetes well controlled 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q25. complications from your diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q26. doing things that your family and friends don’t do 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q27. keeping a record of your blood sugar levels 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q28. the need to eat at regular intervals 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
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Q29. not being able to do housework or other jobs around the house 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q30. a decreased interest in sex 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q31. having to organize your daily life around diabetes 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q32. needing to rest often 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q33. problems in climbing stairs or walking up steps 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q34. having trouble caring for yourself (dressing, bathing, or using the toilet) 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q35. restless sleep 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
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  Q36. walking more slowly than others 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q37. being identified as a diabetic 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q38. having diabetes interfere with your family life 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
 
 
Q39. diabetes in general 
 
Not affected 1 2 3 4 5 6 7 Extremely 
at all        affected 
 
 
OVERALL RATINGS  
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Q1. Please place a cross (Х) on the line below to indicate your overall rating of quality 
of life 
 
Lowest 1 2 3 4 5 6 7 Highest 
quality        quality 
 
 
Q2. Please place a cross (Х) on the line below to show how severe you think your 
diabetes is 
 
Not severe 1 2 3 4 5 6 7 Extremely 
at all        severe 
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…am able to turn my  1 
 
2 
 
3 
 
4 
 
5 
diabetes goals into a Strongly Somewhat Neutral Somewhat Strongly 
 
...know what part(s) of  1 
 
2 
 
3 
 
4 
 
5 
taking  care  of  my  diabetes Strongly Somewhat Neutral Somewhat Strongly 
that I am dissatisfied with. Disagree Disagree  Agree Agree 
 
...can try out different ways  1 
 
2 
 
3 
 
4 
 
5 
of overcoming barriers to Strongly Somewhat Neutral Somewhat Strongly 
my diabetes goals. Disagree Disagree  Agree Agree 
 
...can find ways to feel  1 
 
2 
 
3 
 
4 
 
5 
better about having Strongly Somewhat Neutral Somewhat Strongly 
diabetes. Disagree Disagree  Agree Agree 
 
 
 
Diabetes Empowerment Scale-Short Form (DES-SF) 
 
The 8 items below constitute the DES-SF. The scale is scored by averaging the scores of all completed items (Strongly Disagree 
=1, Strongly Agree = 5) des 
 
Check the box that gives the best answer for you. 
 
 
In general, I believe that I: 
 
 
1. 
 
 
 
 
 
2. 
 
workable plan. 
 
 
 
Disagree 
 
 
 
Disagree 
 
 
 
Agree 
 
 
 
Agree 
 
 
3. 
 
 
 
 
 
4. 
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...know the positive ways I  1 
 
2 
 
3 
 
4 
 
5 
cope with diabetes-related Strongly Somewhat Neutral Somewhat Strongly 
stress. Disagree Disagree  Agree Agree 
 
...can ask for support for  1 
 
2 
 
3 
 
4 
 
5 
having and caring for my Strongly Somewhat Neutral Somewhat Strongly 
diabetes when I need it. Disagree Disagree  Agree Agree 
 
...know what helps me stay  1 
 
2 
 
3 
 
4 
 
5 
motivated to care for my Strongly Somewhat Neutral Somewhat Strongly 
diabetes. Disagree Disagree  Agree Agree 
 
...know enough about myself  1 
 
2 
 
3 
 
4 
 
5 
as a person to make diabetes Strongly Somewhat Neutral Somewhat Strongly 
care choices that are right Disagree Disagree  Agree Agree 
for me.      
 
 
 
5. 
 
 
 
 
 
6. 
 
 
 
 
 
7. 
 
 
 
 
 
8. 
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Copyright © 2004 MacColl Institute for Healthcare Innovation, Group Health Cooperative 
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